BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1219 related articles for article (PubMed ID: 6324595)

  • 1. Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and superoxide anion production.
    Fantone JC; Marasco WA; Elgas LJ; Ward PA
    Am J Pathol; 1984 Apr; 115(1):9-16. PubMed ID: 6324595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic enzyme release and oxygen centered radical formation in human neutrophils are selectively inhibited by E-type prostaglandins but not by PGI2.
    Hecker G; Ney P; Schrör K
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Apr; 341(4):308-15. PubMed ID: 2159112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rat neutrophil activation and effects of lipoxygenase and cyclooxygenase inhibitors.
    Ward PA; Sulavik MC; Johnson KJ
    Am J Pathol; 1984 Aug; 116(2):223-33. PubMed ID: 6087668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin modulation of N-formylmethionylleucylphenylalanine-induced transmembrane potential changes in rat neutrophils.
    Fantone JC; Duque RE; Phan SH
    Biochim Biophys Acta; 1984 Jul; 804(3):265-74. PubMed ID: 6331525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased levels of cyclic adenosine-3',5'-monophosphate in human polymorphonuclear leukocytes after surface stimulation.
    Smolen JE; Korchak HM; Weissmann G
    J Clin Invest; 1980 May; 65(5):1077-85. PubMed ID: 6245105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occult intracellular calcium pools: relevance to neutrophil oxidant production.
    Weisdorf DJ; Thayer MS
    J Lab Clin Med; 1989 Sep; 114(3):260-5. PubMed ID: 2549140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulus-dependent inhibition of superoxide generation by prostaglandins.
    Sedgwick JB; Berube ML; Zurier RB
    Clin Immunol Immunopathol; 1985 Feb; 34(2):205-15. PubMed ID: 2981649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration-dependent regulatory effects of prostaglandin E1 on human neutrophil function in vitro.
    Farmer JC; Burkey TH; Kew RR; Webster RO
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):593-9. PubMed ID: 1654039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of calcium antagonists on the activation of guinea pig neutrophils.
    Azuma Y; Tokunaga T; Takeda Y; Ogawa T; Takagi N
    Jpn J Pharmacol; 1986 Oct; 42(2):243-51. PubMed ID: 3025491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prostaglandin paradox: additive inhibition of neutrophil function by aspirin-like drugs and the prostaglandin E1 analog misoprostol.
    Kitsis EA; Weissmann G; Abramson SB
    J Rheumatol; 1991 Oct; 18(10):1461-5. PubMed ID: 1662723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulus- and cumulative dose-dependent inhibition of O2- production by polymorphonuclear leukocytes of patients receiving corticosteroids.
    Fukushima K; Ando M; Ito K; Suga M; Araki S
    J Clin Lab Immunol; 1990 Nov; 33(3):117-23. PubMed ID: 1967000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory effects of prostaglandin E1: in vivo modulation of the formyl peptide chemotactic receptor on the rat neutrophil.
    Fantone JC; Marasco WA; Elgas LJ; Ward PA
    J Immunol; 1983 Apr; 130(4):1495-7. PubMed ID: 6300229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine inhibition of superoxide anion production by polymorphonuclear leukocytes.
    Yamazaki M; Matsuoka T; Yasui K; Komiyama A; Akabane T
    J Allergy Clin Immunol; 1989 May; 83(5):967-72. PubMed ID: 2541191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostacyclin and beraprost sodium as suppressors of activated rat polymorphonuclear leukocytes.
    Kainoh M; Imai R; Umetsu T; Hattori M; Nishio S
    Biochem Pharmacol; 1990 Feb; 39(3):477-84. PubMed ID: 2154985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface contact inhibits neutrophil superoxide generation induced by soluble stimuli.
    Hoffstein ST; Gennaro DE; Manzi RM
    Lab Invest; 1985 May; 52(5):515-22. PubMed ID: 2985869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the inhibitory effects of PGE2 and selective EP agonists on chemotaxis of human neutrophils.
    Armstrong RA
    Br J Pharmacol; 1995 Dec; 116(7):2903-8. PubMed ID: 8680723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human polymorphonuclear leukocyte functions by ibuprofen.
    Nielsen VG; Webster RO
    Immunopharmacology; 1987 Feb; 13(1):61-71. PubMed ID: 3032852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of six prostaglandins, prostacyclin and iloprost on generation of superoxide anions by human polymorphonuclear leukocytes stimulated by zymosan or formyl-methionyl-leucyl-phenylalanine.
    Gryglewski RJ; Szczeklik A; Wandzilak M
    Biochem Pharmacol; 1987 Dec; 36(24):4209-13. PubMed ID: 2446631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lag period for superoxide anion generation and lysosomal enzyme release from human neutrophils: effects of calcium antagonists and anion channel blockers.
    Smolen JE
    J Lab Clin Med; 1984 Jul; 104(1):1-10. PubMed ID: 6330249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of local anesthetics on migration, extracellular release of lysosomal enzyme, and superoxide anion production in human polymorphonuclear leukocytes.
    Sasagawa S
    Immunopharmacol Immunotoxicol; 1991; 13(4):607-22. PubMed ID: 1663527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.